-
Listing
Connecting Europe's Fixed Income MarketsOne connected fixed income ecosystemΔιαβάστε περισσότεραSeamless listing, trading, clearing and settlement for fixed income
-
Trading
Connecting Europe's Fixed Income MarketsOne connected fixed income ecosystemΔιαβάστε περισσότερα
Seamless listing, trading, clearing and settlement for fixed income
-
Clearing
Connecting Europe's Fixed Income MarketsOne connected fixed income ecosystemΔιαβάστε περισσότερα
Seamless listing, trading, clearing and settlement for fixed income
-
CSD
European CSD modelBuilding the CSD of Choice in EuropeΔιαβάστε περισσότεραEuronext Securities is shaping the future of European capital markets by enhancing integration, connectivity, and innovation.
-
Technology
Euronext Technology SolutionsHigh-Frequency Trading Solution (HFTS)Διαβάστε περισσότεραThe new generation of high-frequency risk trading platforms, offering the highest performance with ultra-low latency and minimal jitter, all at a low total cost of ownership.
-
Data
-
Indices
Access the white paperNext generation of indicesΔιαβάστε περισσότεραThis white paper marks the second edition of Euronext’s Index Outlook series, a recurring publication designed to give investors deeper insight into our index innovation agenda and the structural forces shaping global markets.
-
About Euronext
Euronext strategic planInnovate for Growth 2027Διαβάστε περισσότεραShaping capital markets for future generations
European Biotech SME Forum
27/09/2016
Bell Ceremony to open the European Biotech SME Forum
On 27 September 2016, Robert Madelin, EU’s Senior Advisor for Innovation and Nathalie Moll, EuropaBio Secretary General opened the European stock markets of Euronext to highlight the potential of this growing biotech sector.
The Bell Ceremony is followed by a 1-day conference in Euronext’s premises with different international high level speakers and biotech CEO’s. This event includeded a ceremony for the Most Innovative European Biotech SME Awards.
To find out more about the programme and the speakers, please consult the EuropaBio website:www.biotechweek.org